ファイブリノゲンの血管活性作用は,サフェノス静脈に作用する

R C Hicks¹, J Golledge, R Mir-Hasseine

¹Cardiovascular & Pulmonary Research Division, Charing Cross & Westminster Medical School, London, UK.

Nature

|February 29, 1996

まとめ

ファイブリノゲンは血管機能に影響を与え,静脈移植ではリラックス,再収縮を引き起こします. これは,繊維素が複雑なシグナル伝達経路を通じて静脈移植疾患に寄与することを示唆しています.

科学分野:

血管生物学血管生物学
心血管研究循環器科の研究
ヘモスタシスヘモスタシスとは

背景:

血の正常なフィブリノゲンは,血液静止に不可欠である.
フィブリノゲン濃度の上昇は,動脈硬化症やサフェノス静脈バイパス移植狭窄症のリスクを高めます.
静脈移植狭窄症は,内側の滑らかな筋肉細胞の増殖を伴うもので,狭窄と血栓性閉塞につながる.

研究の目的:

ファイブリノゲンとファイブリノペプチドがサフェノス静脈のリングに及ぼす血管活性効果を調査する.
静脈移植に対するフィブリノゲンの作用の基礎となるメカニズムを探求し,潜在的に移植病理と関連付けます.

主な方法:

孤立したサフェノス静脈のリングを用いた臓器浴の研究.
異なる濃度のフィブリノゲンとフィブリノペプチドを投与する.
リラックスと再収縮の反応の評価.
K+チャネルブロッカーと抗ICAM-1抗体を用いた抑制研究.

主要な成果:

フィブリノペプチドは静脈のリングに血管活性効果を示さなかった.
低濃度 (0〜2マイクロM) でフィブリノゲン誘発の内皮依存リラクゼーション.
線維素素濃度の上昇は再収縮につながった.
フィブリノゲン媒介のリラクゼーションは,K+チャネルブロッカーとICAM-1抗体によって弱まった.

結論:

ファイブリノゲンは,フィブリノペプチドではなく,内皮に依存した方法でサフェノス静脈トーンに影響を与えます.
この発見は,K+チャネルとICAM-1を含む結合信号伝達経路が,フィブリノゲンの効果を媒介することを示唆しています.
これらのメカニズムは,線維素濃度と静脈移植病理学の関連に寄与する可能性があります.

さらに関連する動画

08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

09:10

Human Saphenous Vein Endothelial Cell Isolation and Exposure to Controlled Levels of Shear Stress and Stretch

Published on: April 21, 2023

関連する概念動画

01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

01:15

Veins of Lower Limbs

The human body consists of an intricate network of veins responsible for the crucial task of blood drainage from the lower limbs. These veins can be categorized into two main types: deep veins and superficial veins.
Formed by the union of the medial and lateral plantar veins, the posterior tibial vein, rising through the calf muscle, assimilates the fibular vein. The anterior tibial vein, a superior extension of the foot's dorsalis pedis vein, merges with the posterior tibial vein at the knee,...

01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

関連する実験動画